生物相似性FDA的观点

关键字：类型：

下载页码(大于等于0,小于360)：

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

生物相似性FDA的观点 1558条(本栏目收费,不能显示细节,电话13136136841)

Ixiaro,44 44

Japan biosimilars in,40 40

Japanese encephalitis vaccine,44 44

Jetrea,44 44

Kadcyla,45 45

Kalbitor,45 45

Kepivance,42 42

Kineret,44 44

Kjeldahl analysis,229 229

Kozlowski Steven Dr.,130–131 131

Label copy,39 39

Labeling for reference product,121–122 122

Landscape biosimilar products,29–46 46

Protein aggregates,293 293

Panitumumab,43 43

Paracrine signaling,2 2

Parallel design,96 96

Parathyroid hormone,44 44

Patient Protection and Affordable Care Act,31,88 88

Pediarix,42 42

Pediatric Research Equity Act(PREA),51,119–122 122

Pediatric study plan (PSP),122–123 123

Pediatric study waiver,39 39

Pegaptanib sodium,42 42

Pegasys,43 43

Pegfilgrastim,42 42

Peginterferon alfa-2a,43 43

Peginterferon alfa-2b,42 42

PEGIntron,42 42

Pegvisomant,42 42

最新招商产品更多>>

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：